An interventional study of Pigtail catheter in Pleural Effusion, sponsored by Sherief Abd-Elsalam. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2017-12-27.
Sponsored by Sherief Abd-Elsalam · Not applicable, Interventional, and Treatment
The effectiveness of pigtail catheter as a less invasive option for pleural drainage in patients with resistant hepatic hydrothorax.
Hepatic hydrothorax (HH) is defined as a transudative pleural effusion in patients with liver cirrhosis in the absence of cardiopulmonary disease. The estimated prevalence among patients with liver cirrhosis is approximately 5-6% (Baikati et al., 2014).
HH is an infrequent but a well-known complication of portal hypertension. Trans-diaphragmatic passage of ascitic fluid from peritoneal to the pleural cavity through numerous diaphragmatic defects has been shown to be the predominant mechanism in the formation of HH (Kumar\&Kumar, 2014).
Patients with hepatic hydrothoraces often have few options (Goto et al., 2011). Diuretic-resistant HH could be managed with liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS) or indwelling pleural catheters. However, tube thoracotomy and pleurodesis failed in most patients (Singh et al., 2013).
Case reports and small case series have reported a high rate of complications associated with chest tube placement for hepatic hydrothorax. The most common reported complications were acute kidney injury, pneumothorax, and empyema. Death has been recorded in some cases. Chest tube insertion for hepatic hydrothorax carries significant morbidity and mortality, with questionable benefit (Orman\&Lok, 2009).
Pigtail catheter insertion is an effective and safe method of draining pleural fluid. Its use is safe and recommended for all cases of pleural effusion requiring chest drain except for empyema and other loculated effusions that yielded low success rate (Bediwy and Amer, 2012).
324 studies on the registry are indexed under Pleural Effusion; 62 are open to participants now.
This study's planned enrollment of 30 is below the median of 63 across 212 interventional studies indexed under Pleural Effusion.
Browse Pleural Effusion studies →Sherief Abd-Elsalam is the lead sponsor of 50 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pleural fluid should be transudate according to Light's criteria:
Exclusion Criteria:
Pigtail catheter for pleural drainage of recurrent hepatic hydrothorax
Device: Pigtail catheter
pigtail catheter for pleural drainage
Change in chest radiography
Time frame: baseline, daily after treatment within admission
Chest X-ray and any complications recorded
Time frame: weekly in first month and monthly for 3 months
This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sherief Abd-Elsalam